Companies Cryptocurrencies
Jounce Therapeutics Inc
Jounce Therapeutics Inc
Exchange: Nasdaq Global Select
IPO Date: 26/01/2017
CEO: Dr. Richard Murray
Biotechnology Healthcare 🔗
  • JNCE
    symbol
  • 9
    price
  • 461088000
    market cap
  • -0.01000023
    changes
If you bought

shares of Jounce Therapeutics Inc (JNCE) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which treat cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. The company is headquartered in Cambridge, Massachusetts and currently employs 128 full-time employees. The firm is engaged in transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. The Company’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates Inducible T cell CO-Stimulator (ICOS) and is in a Phase II trial.

Address: 780 Memorial Dr Cambridge MASSACHUSETTS 02139

Stay updated.